Detalles de la búsqueda
1.
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.
Br J Haematol
; 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38442902
2.
Relationship between clone metrics and clinical outcome in clonal cytopenia.
Blood
; 138(11): 965-976, 2021 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255818
3.
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients.
Genes Immun
; 23(1): 51-56, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952932
4.
B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
Hematol Oncol
; 40(4): 658-666, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460540
5.
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.
Hematol Oncol
; 38(5): 689-697, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738175
6.
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
Br J Haematol
; 187(4): 441-446, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31276195
7.
Clinical significance of somatic mutation in unexplained blood cytopenia.
Blood
; 129(25): 3371-3378, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424163
8.
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
Am J Hematol
; 94(11): 1193-1199, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31378966
9.
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
Blood
; 128(10): 1408-17, 2016 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27385790
10.
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.
Hematol Oncol
; 41(3): 574-577, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36218059
11.
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Haematologica
; 102(12): 2077-2085, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28983055
12.
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.
Am J Hematol
; 97(4): E135-E138, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041232
13.
JAK inhibitors and risk of B-cell lymphomas.
Blood
; 133(21): 2251-2253, 2019 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31122940
14.
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia.
Am J Hematol
; 96(11): E404-E408, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34329489
15.
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
Am J Hematol
; 96(6): E210-E214, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33755245
16.
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
Blood
; 121(13): 2522-8, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23355535
17.
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
Blood
; 119(1): 188-91, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22072557
18.
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.
Am J Hematol
; 94(7): E185-E188, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30972817
19.
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
Haematologica
; 98(4): 635-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23349307
20.
Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Hematol Oncol
; 31(3): 136-42, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23060227